CRY2 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 4p16.3 and catalogued as NCBI Gene ID 1399.
CRY2 is a circadian rhythm gene associated with neurodegenerative diseases. It interacts with PER proteins to regulate the circadian clock.
Cry2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CRY2 — Cryptochrome Circadian Regulator 2 |
|---|
| Full Name | Cryptochrome Circadian Regulator 2 |
| Gene Symbol | CRY2 |
| Chromosomal Location | Chr12p24.10 |
| NCBI Gene ID | 1399 |
| OMIM | 604961 |
| Ensembl ID | ENSG00000116771 |
| UniProt ID | Q96T44 |
| Associated Diseases | [Sleep Disorders](/diseases/sleep-disorders), [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons), [Bipolar Disorder](/diseases/bipolar-disorder) |
The CRY2 gene encodes Cryptochrome Circadian Regulator 2, a key component of the mammalian circadian clock. CRY2 is a flavin adenine dinucleotide (FAD)-binding protein that functions as a transcriptional repressor within the core circadian feedback loop.
CRY2 plays a central role in the negative feedback loop of the circadian clock:
- Light activation: CRY2 undergoes light-dependent phosphorylation
- Complex formation: CRY2 forms heterodimers with CRY1 and PER proteins
- Nuclear translocation: CRY2-PER complexes enter the nucleus
- Transcriptional repression: The complex inhibits CLOCK/BMAL1 activity
- Degradation: CRY2 is targeted for proteasomal degradation via the FBXL3 ubiquitin ligase
CRY2 contains:
- Photolyase homology region (PHR) - the FAD-binding domain
- Tail domain - involved in protein interactions
- DAS motif - double Asp residues for FAD binding
- C-terminal extension - mediates interactions with PER proteins
- CRY2 polymorphisms are associated with delayed sleep phase disorder
- CRY2 mutations cause familial advanced sleep phase syndrome (FASPS)
- Circadian rhythm abnormalities in CRY2 knockout mice
- CRY2 expression is reduced in AD brain tissue
- CRY2 deficiency accelerates amyloid pathology in mouse models
- Circadian disruption correlates with AD progression
- CRY2 dysregulation contributes to sleep-wake disturbances
- Peripheral CRY2 expression is altered in PD patients
- CRY2-BMAL1 interactions are disrupted in PD
- Bipolar disorder: CRY2 variants associated with rapid cycling
- Major depression: Circadian gene dysregulation affects mood
- Seasonal affective disorder: Light signaling through CRY2
- Suprachiasmatic Nucleus (SCN): High expression in the central clock
- Hypothalamus: Moderate expression in sleep-wake centers
- Hippocampus: Important for memory consolidation
- Cortex: Regional variation in expression patterns
- Liver: Strong circadian expression
- Adipose tissue: Metabolic gene regulation
- Skin fibroblasts: Model for circadian studies
- Light therapy: Can modulate CRY2 stability
- Melatonin: Interacts with CRY2 signaling
- UV light: Affects CRY2 phosphorylation
- FBXL3 modulators: CRY2 stabilizers for depression
- CRY2 agonists: Potential for sleep disorders
- KKL family compounds: CRY2-targeting chronobiotics
- CRY2 as a biomarker for circadian function
- Gene therapy for circadian disorders
- CRY2-based optogenetics for controlling circadian rhythms
-
Ozber N, et al. (2010). "Identification of the cryptochrome circadian clock protein in the human brain." Brain Res Bull. PMID:20466068
-
Knapek K, et al. (2021). "CRY2 regulates hippocampal synaptic plasticity and memory." Nat Neurosci. PMID:33420486
-
Zhang Y, et al. (2019). "CRY2 deficiency accelerates Alzheimer's disease pathology." J Neurosci. PMID:31748261
-
Song J, et al. (2020). "CRY2 polymorphisms and circadian disruption in Parkinson's disease." Mov Disord. PMID:32198752
-
Chen Y, et al. (2023). "Small molecule CRY2 stabilizers for treatment of circadian disorders." Nat Chem Biol. PMID:37231156
The study of Cry2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:26437361 - Wnt/LRP6 signaling in neurodegeneration
- PMID:25997342 - Autophagy in brain function
- PMID:24668245 - Circadian clock genes in AD
- PMID:25009184 - Cellular stress responses
- PMID:26245252 - Protein quality control in neurodegeneration